Artemisia iwayomogi extract attenuates high-fat diet-induced obesity by decreasing the expression of genes associated with adipogenesis in mice

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Choi, Yeji ^a   Yanagawa, Yasuko ^a   Kim, Sungun ^b   Whang, Wan Kyunn ^b   Park, Taesun ^a  

^a Yonsei University   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIOBESITY AGENT; ARTEMISIA IWAYOMOGI EXTRACT; BETA INTERFERON; CD36 ANTIGEN; INTERLEUKIN 6; LEPTIN; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTEMISIA; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; EPIDIDYMIS; GENE EXPRESSION; GENE TARGETING; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID DIET; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL;

EID: 84873373975     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/915953     Document Type: Article

References (50)

1. Rangwala S. M., Lazar M. A., Transcriptional control of adipogenesis. Annual Review of Nutrition 2000 20 535 559 2-s2.0-0033830783 10.1146/annurev.nutr.20.1.535
2. Lakka H. M., Laaksonen D. E., Lakka T. A., Niskanen L. K., Kumpusalo E., Tuomilehto J., Salonen J. T., The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of the American Medical Association 2002 288 21 2709 2716 2-s2.0-0037021505 10.1001/jama.288.21. 2709 (Pubitemid 35403784)
3. Perley M., Kipnis D. M., Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects. Diabetes 1966 15 12 867 874 2-s2.0-0013990334
4. Kim S., Jin Y., Choi Y., Park T., Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochemical Pharmacology 2011 81 11 1343 1351 2-s2.0-79955611314 10.1016/j.bcp.2011.03.012
5. Yamauchi T., Waki H., Kamon J., Murakami K., Motojima K., Komeda K., Miki H., Kubota N., Terauchi Y., Tsuchida A., Tsuboyama-Kasaoka N., Yamauchi N., Ide T., Hori W., Kato S., Fukayama M., Akanuma Y., Ezaki O., Itai A., Nagai R., Kimura S., Tobe K., Kagechika H., Shudo K., Kadowaki T., Inhibition of RXR and PPAR γ ameliorates diet-induced obesity and type 2 diabetes. Journal of Clinical Investigation 2001 108 7 1001 1013 2-s2.0-0034740754 10.1172/JCI200112864 (Pubitemid 32946074)
6. Wang N. D., Finegold M. J., Bradley A., Ou C. N., Abdelsayed S. V., Wilde M. D., Taylor L. R., Wilson D. R., Darlington G. J., Impaired energy homeostasis in C/EBP α knockout mice. Science 1995 269 5227 1108 1112 2-s2.0-0029160028
7. Bertin E., Nguyen P., Guenounou M., Durlach V., Potron G., Leutenegger M., Plasma levels of tumor necrosis factor-alpha (TNF- α) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes and Metabolism 2000 26 3 178 182 2-s2.0-0033920370 (Pubitemid 30435762)
8. Fain J. N., Madan A. K., Hiler M. L., Cheema P., Bahouth S. W., Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004 145 5 2273 2282 2-s2.0-2042480671 10.1210/en.2003-1336 (Pubitemid 38535056)
9. Hotamisligil G. S., Shargill N. S., Spiegelman B. M., Adipose expression of tumor necrosis factor- α: direct role in obesity-linked insulin resistance. Science 1993 259 5091 87 91 2-s2.0-0027459878 (Pubitemid 23036092)
10. Xu H., Barnes G. T., Yang Q., Tan G., Yang D., Chou C. J., Sole J., Nichols A., Ross J. S., Tartaglia L. A., Chen H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003 112 12 1821 1830 2-s2.0-9144223683 10.1172/JCI200319451 (Pubitemid 38063705)
11. Maachi M., Piéroni L., Bruckert E., Jardel C., Fellahi S., Hainque B., Capeau J., Bastard J. P., Systemic low-grade inflammation is related to both circulating and adipose tissue TNF α leptin and IL-6 levels in obese women. International Journal of Obesity 2004 28 8 993 997 2-s2.0-3242889982 10.1038/sj.ijo.0802718 (Pubitemid 38998704)
12. Kim S. J., Choi Y., Choi Y. H., Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice. The Journal of Nutritional Biochemistry 2012 23 2 113 122
13. Kim S. H., Choi C. H., Kim S. Y., Eun J. S., Shin T. Y., Anti-allergic effects of Artemisia iwayomogi on mast cell-mediated allergy model. Experimental Biology and Medicine 2005 230 1 82 88 2-s2.0-11144252694
14. Ji H. J., Yeo H. K., Lee N. H., Hwang J. S., Koo K. A., Cheong S. W., Park J. H., Oh G. S., Yoon C. S., Youn H. J., A carbohydrate fraction, AIP1, from Artemisia iwayomogi down-regulates Fas gene expression and suppresses apoptotic death of the thymocytes induced by 2,3,7,8-tectrachlorodibenzo-p- dioxin. Biotechnology Letters 2005 27 4 253 257 2-s2.0-20144371842 10.1007/s10529-004-8294-2 (Pubitemid 40374627)
15. Hwang J. S., Ji H. J., Koo K. A., Lee N. H., Yeo H. K., Cheong S. W., Park J. H., Oh G. S., Yoon C. S., Youn H. J., AIP1, a water-soluble fraction from Artemisia iwayomogi, suppresses thymocyte apoptosis in vitro and down-regulates the expression of fas gene. Biological and Pharmaceutical Bulletin 2005 28 5 921 924 2-s2.0-21144439269 10.1248/bpb.28.921 (Pubitemid 40740670)
16. Ding Y., Kim J. A., Yang S. Y., Kim W. K., Lee S. H., Jang H. D., Antioxidative sesquiterpenes from Artemisia iwayomogi. Notes 2011 32 9 3493
17. Sang-Myung N., Seung-Shi H., Duk-Hwan O., Il-Jun K., Sang-Young L., Effects of Artemisia iwayomogi kitamura ethanol extract on lowering serum and liver lipids in rats. Journal of the Korean Society of Food Science and Nutrition 1998 27 2 338 343
18. Cho S. Y., Jeong H. W., Sohn J. H., Seo D. B., Kim W. G., An ethanol extract of Artemisia iwayomogi activates PPARdelta leading to activation of fatty acid oxidation in skeletal muscle. PloS ONE 2012 7 3 e33815
19. Folch J., Folch M., Sloane Stanley G. H., A simple method for the isolation and purification of total lipides from animal tissues. The Journal of Biological Chemistry 1957 226 1 497 509 2-s2.0-70449158340
20. Mapfei M., Halaas J., Ravussin E., Pratley R. E., Lee G. H., Zhangs Y., Fei H., Kim S., Lallone R., Ranganathan S., Kern P. A., Friedman J. M., Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine 1995 1 11 1155 1161 2-s2.0-0028845877
21. Wang G., Liu X., Christoffel K. K., Zhang S., Wang B., Liu R., Li Z., Liu X., Brickman W. J., Zimmerman D., Xu X., Wang X., Prediabetes is not all about obesity: association between plasma leptin and prediabetes in lean rural Chinese adults. European Journal of Endocrinology 2010 163 2 243 249 2-s2.0-77955393672 10.1530/EJE-10-0145
22. Kubota N., Terauchi Y., Miki H., Tamemoto H., Yamauchi T., Komeda K., Satoh S., Nakano R., Ishii C., Sugiyama T., Kazuhiro E., Tsubamoto Y., Okuno A., Murakami K., Sekihara H., Hasegawa G., Naito M., Toyoshima Y., Tanaka S., Shiota K., Kitamura T., Fujita T., Ezaki O., Aizawa S., Nagai R., Tobe K., Kimura S., Kadowaki T., PPAR γ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Molecular Cell 1999 4 4 597 609 2-s2.0-0033212964 10.1016/S1097-2765(00)80210-5 (Pubitemid 29531139)
23. Hertzel A. V., Bernlohr D. A., Regulation of adipocyte gene expression by polyunsaturated fatty acids. Molecular and Cellular Biochemistry 1998 188 1-2 33 39 2-s2.0-0002053167 10.1023/A:1006883303023 (Pubitemid 28493315)
24. Tontonoz P., Hu E., Graves R. A., Budavari A. I., Spiegelman B. M., mPPAR γ 2: tissue-specific regulator of an adipocyte enhancer. Genes and Development 1994 8 10 1224 1234 2-s2.0-0028180070
25. Tontonoz P., Nagy L., Alvarez J. G. A., Thomazy V. A., Evans R. M., PPAR γ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998 93 2 241 252 2-s2.0-0032540012 10.1016/S0092-8674(00)81575-5 (Pubitemid 28180857)
26. Phan J., Péterfy M., Reue K., Lipin expression preceding peroxisome proliferator-activated receptor- γ is critical for adipogenesis in vivo and in vitro. Journal of Biological Chemistry 2004 279 28 29558 29564 2-s2.0-3142685480 10.1074/jbc.M403506200 (Pubitemid 38915837)
27. Sul H. S., Wang D., Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. Annual Review of Nutrition 1998 18 331 351 2-s2.0-0031845136 10.1146/annurev.nutr.18.1.331 (Pubitemid 28366871)
28. Coburn C. T., Knapp F. F. Jr., Febbraio M., Beets A. L., Silverstein R. L., Abumrad N. A., Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. Journal of Biological Chemistry 2000 275 42 32523 32529 2-s2.0-0034693232
29. Tzameli I., Fang H., Ollero M., Shi H., Hamm J. K., Kievit P., Hollenberg A. N., Flier J. S., Regulated production of a peroxisome proliferator-activated receptor- γ ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. Journal of Biological Chemistry 2004 279 34 36093 36102 2-s2.0-4143099405 10.1074/jbc.M405346200 (Pubitemid 39100617)
30. Boden G., Obesity and free fatty acids. Endocrinology and Metabolism Clinics of North America 2008 37 3 635 646 2-s2.0-50449086746 10.1016/j.ecl.2008.06.007
31. Ruan H., Hacohen N., Golub T. R., Van Parijs L., Lodish H. F., Tumor necrosis factor- α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor- B activation by TNF- α is obligatory. Diabetes 2002 51 5 1319 1336 2-s2.0-0036313033 (Pubitemid 34826596)
32. Suganami T., Nishida J., Ogawa Y., A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor α Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 10 2062 2068 2-s2.0-26244448904 10.1161/01.ATV.0000183883.72263.13 (Pubitemid 41416301)
33. Castell J. V., Gomez-Lechon M. J., David M., Fabra R., Trullenque R., Heinrich P. C., Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990 12 5 1179 1186 2-s2.0-0025228036 10.1002/hep.1840120517
34. Burstein S. A., Peng J., Friese P., Wolf R. F., Harrison P., Downs T., Hamilton K., Comp P., Dale G. L., Cytokine-induced alteration of platelet and hemostatic function. Stem Cells 1996 14 1 154 162 2-s2.0-0030307680 (Pubitemid 126687204)
35. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K. I., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., Kasuga M., MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. Journal of Clinical Investigation 2006 116 6 1494 1505 2-s2.0-33745216724 10.1172/JCI26498
36. Sareneva T., Matikainen S., Kurimoto M., Julkunen I., Influenza A virus-induced IFN- α / β and IL-18 synergistically enhance IFN- γ gene expression in human T cells. Journal of Immunology 1998 160 12 6032 6038 2-s2.0-0032526917 (Pubitemid 28298066)
37. Moller D. E., Potential role of TNF- α in the pathogenesis of insulin resistance and type 2 diabetes. Trends in Endocrinology and Metabolism 2000 11 6 212 217 2-s2.0-0033867178 10.1016/S1043-2760(00)00272-1 (Pubitemid 30603166)
38. Klover P. J., Zimmers T. A., Koniaris L. G., Mooney R. A., Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 2003 52 11 2784 2789 2-s2.0-0242268894 10.2337/diabetes.52.11.2784 (Pubitemid 37339708)
39. Kamei N., Tobe K., Suzuki R., Ohsugi M., Watanabe T., Kubota N., Ohtsuka-Kowatari N., Kumagai K., Sakamoto K., Kobayashi M., Yamauchi T., Ueki K., Oishi Y., Nishimura S., Manabe I., Hashimoto H., Ohnishi Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Nagai R., Kadowaki T., Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. Journal of Biological Chemistry 2006 281 36 26602 26614 2-s2.0-33748750917 10.1074/jbc.M601284200 (Pubitemid 44401869)
40. Feinstein R., Kanety H., Papa M. Z., Lunenfeld B., Karasik A., Tumor necrosis factor- α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. Journal of Biological Chemistry 1993 268 35 26055 26058 2-s2.0-0027332738
41. Cohen B., Novick D., Rubinstein M., Modulation of insulin activities by leptin. Science 1996 274 5290 1185 1188 2-s2.0-0029860791 10.1126/science.274. 5290.1185 (Pubitemid 26389283)
42. Zhao Z., Hu Y., Liang Z., Yuen J. P. S., Jiang Z., Leung K. S. Y., Authentication is fundamental for standardization of Chinese medicines. Planta Medica 2006 72 10 865 874 2-s2.0-33748704528 10.1055/s-2006-947209 (Pubitemid 44389273)
43. Kim A. R., Zou Y. N., Park T. H., Shim K. H., Kim M. S., Kim N. D., Kim J. D., Bae S. J., Choi J. S., Chung H. Y., Active components from Artemisia iwayomogi displaying ONOO-scavenging activity. Phytotherapy Research 2004 18 1 1 7 2-s2.0-10744228734 10.1002/ptr.1358 (Pubitemid 38173494)
44. Yu H. H., Kim Y. H., Kil B. S., Kim K. J., Jeong S. I., You Y. O., Chemical composition and antibacterial activity of essential oil of Artemisia iwayomogi. Planta Medica 2003 69 12 1159 1162 2-s2.0-1242284434 10.1055/s-2003-818011 (Pubitemid 38223363)
45. Ding Y., Liang C., Yang S. Y., Ra J. C., Choi E. M., Kim J. A., Ho Kim Y., Phenolic compounds from Artemisia iwayomogi and their effects on osteoblastic MC3T3-E1 cells. Biological and Pharmaceutical Bulletin 2010 33 8 1448 1453 2-s2.0-77956131069 10.1248/bpb.33.1448
46. Han J. M., Kim H. G., Choi M. K., Aqueous extract of Artemisia iwayomogi Kitamura attenuates cholestatic liver fibrosis in a rat model of bile duct ligation. Food and Chemical Toxicology 2012 50 10 3505 3513
47. Wang J. H., Choi M. K., Shin J. W., Hwang S. Y., Son C. G., Antifibrotic effects of Artemisia capillaris and Artemisia iwayomogi in a carbon tetrachloride-induced chronic hepatic fibrosis animal model. Journal of Ethnopharmacology 2012 140 1 179 185
48. Shin E., Choi K. M., Yoo H. S., Lee C. K., Hwang B. Y., Lee M. K., Inhibitory effects of coumarins from the stem barks of fraxinus rhynchophylla on adipocyte differentiation in 3T3-L1 cells. Biological and Pharmaceutical Bulletin 2010 33 9 1610 1614 2-s2.0-77957595091 10.1248/bpb.33.1610
49. Hwang J. T., Kim S. H., Hur H. J., Decursin, an active compound isolated from Angelica gigas, inhibits fat accumulation, reduces adipocytokine secretion and improves glucose tolerance in mice fed a high-fat diet. Phytotherapy Research 2012 26 5 633 638
50. Dharmarajan S. K., Arumugam K. M., Comparative evaluation of flavone from Mucuna pruriens and coumarin from Ionidium suffruticosum for hypolipidemic activity in rats fed with high Fat diet. Lipids in Health and Disease 2012 11, article 126